Thailand - Delayed Quote THB

Bumrungrad Hospital Public Company Limited (BH.BK)

Compare
207.00 -3.00 (-1.43%)
At close: 4:37 PM GMT+7
Currency in THB All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
25,760,851.56
25,376,158.56
20,720,563.66
12,460,420.94
12,362,100.37
Cost of Revenue
12,576,068.87
12,894,825.87
11,099,259.81
7,730,980.53
7,677,335.49
Gross Profit
13,184,782.69
12,481,332.69
9,621,303.85
4,729,440.41
4,684,764.88
Operating Expense
4,041,820.67
4,009,390.67
3,610,975.20
3,151,810.29
3,316,420.86
Operating Income
9,142,962.02
8,471,942.02
6,010,328.65
1,577,630.12
1,368,344.02
Net Non Operating Interest Income Expense
255,186.89
138,554.89
42,407.48
-50,971.42
272.02
Other Income Expense
-10,929.67
27,158.34
-3,780.64
-70,779.03
2,319.27
Pretax Income
9,387,219.25
8,637,655.25
6,048,955.49
1,455,879.68
1,370,935.31
Tax Provision
1,732,886.60
1,582,523.60
1,072,193.32
215,846.91
149,681.02
Net Income Common Stockholders
7,592,592.98
7,006,450.98
4,938,221.85
1,215,678.23
1,204,137.57
Diluted NI Available to Com Stockholders
7,592,592.98
7,006,450.98
4,938,221.85
1,215,678.23
1,204,137.57
Basic EPS
9.55
8.81
6.21
1.53
1.54
Diluted EPS
8.76
8.08
5.69
1.40
1.39
Basic Average Shares
794,908.50
794,886.00
794,838.00
794,586.00
781,653.00
Diluted Average Shares
867,415.00
867,415.00
867,415.00
867,415.00
867,415.00
Total Operating Income as Reported
9,132,392.65
8,499,997.65
6,007,057.98
1,519,269.04
1,373,040.42
Rent Expense Supplemental
--
71,031.00
46,112.00
--
39,980.00
Total Expenses
16,617,889.54
16,904,216.54
14,710,235.00
10,882,790.82
10,993,756.35
Net Income from Continuing & Discontinued Operation
7,592,592.98
7,006,450.98
4,938,221.85
1,215,678.23
1,204,137.57
Normalized Income
7,601,211.24
6,983,535.49
4,940,912.79
1,265,386.77
1,199,953.93
Interest Income
262,582.46
140,948.46
45,954.27
68,784.48
127,891.03
Interest Expense
7,395.57
2,393.57
3,546.79
119,755.90
127,619.01
Net Interest Income
255,186.89
138,554.89
42,407.48
-50,971.42
272.02
EBIT
9,394,614.82
8,640,048.82
6,052,502.28
1,575,635.58
1,498,554.31
EBITDA
10,471,497.82
9,736,816.82
7,169,377.28
2,755,557.21
2,718,656.18
Reconciled Cost of Revenue
12,576,068.87
12,894,825.87
11,099,259.81
7,730,980.53
7,677,335.49
Reconciled Depreciation
1,076,883.00
1,096,768.00
1,116,875.00
1,179,921.64
1,220,101.87
Net Income from Continuing Operation Net Minority Interest
7,592,592.98
7,006,450.98
4,938,221.85
1,215,678.23
1,204,137.57
Total Unusual Items Excluding Goodwill
-10,569.38
28,055.62
-3,270.68
-58,361.08
4,696.40
Total Unusual Items
-10,569.38
28,055.62
-3,270.68
-58,361.08
4,696.40
Normalized EBITDA
10,482,067.20
9,708,761.20
7,172,647.96
2,813,918.29
2,713,959.78
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,951.11
5,140.13
-579.74
-8,652.54
512.76
12/31/2020 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers